Lifeline Biotechnologies, Inc. engages in the development and marketing of technology, applications, and medical devices. It is involved in the development of The First Warning System for assisting in the early detection of breast cancer. The company was founded by William Reeves in 1994 and is headquartered in Denton, TX.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Lifeline Biotechnologies Inc. market cap is $1.74M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lifeline Biotechnologies Inc. 52 week high is $0.0011 as of November 22, 2026.
Lifeline Biotechnologies Inc. stock price today is $0.0004.
Lifeline Biotechnologies Inc. stock price yesterday was $0.0004.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Lifeline Biotechnologies Inc. P/B ratio is -13.3333.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Lifeline Biotechnologies Inc. 50-day moving average is $0.0004.